University of California San Francisco

Immunological Differences in Atopic Dermatitis Across Age Groups: Insights from Single-Cell Multi-Omics. (41394559)

Baldonado GCL, Kumar S, Jin J, Fang X, Ildardashty A, Braun M, Neuhaus IM, Mathes E, Bhutani T, Liao W PMID: 41394559

Immunological Differences in Atopic Dermatitis Across Age Groups: Insights from Single-Cell Multi-Omics. (41394559)

Baldonado GCL, Kumar S, Jin J, Fang X, Ildardashty A, Braun M, Neuhaus IM, Mathes E, Bhutani T, Liao W PMID: 41394559

Biologic therapy and risk of mental health diagnosis in patients with hidradenitis suppurativa. (41308732)

Ofori-Darko A, Barzallo D, Sinnott SM, Naik HB, Hernandez-Boussard T, Amonoo HL, Barnes LA PMID: 41308732

Dupilumab Reduces Pruritus in Clinically Distinct Dermatologic Diseases: Data from Clinical Trials on Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria. (41272364)

Yosipovitch G, Kim BS, Koo JY, Chen Z, Wiggins S, Zahn J, Sugerman P, Haddad EB, Cyr SL PMID: 41272364

Alpelisib, a PI3Kα inhibitor, effectively treats vascular anomalies with diverse genotypes and phenotypes. (41623364)

Pithadia DJ, Heskel MJ, Shotayev A, Davda S, Durand R, Cooke D, Czechowicz J, Lesh M, Cornett P, Shimano KA, Mathes EF, Frieden IJ, Apsel Winger B PMID: 41623364

WHO classification of skin tumours: key updates in the fifth edition. (41263762)

Goldman-Lévy G, Barnhill R, Bastian BC, Kempf W, Elder D, Gerami P, Grayson W, Kazakov D, Massi D, Messina J, de la Fouchardière A, Lazar AJ, Brenn T, Rous B, Field A, Gill A, Hodge JC, Khoury JD, Leite K, Sayed S, Tan PH, Elenitsas R, Calonje E, Duncan LM, Zhiyong L, Moch H, Singh R, Wijesinghe H, Cree I, Lokuhetty D PMID: 41263762

Sexual and gender minority inclusivity in hidradenitis suppurativa patient-reported outcome measures. (40591730)

Jia JL, Sun KH, Naik HB, Barnes LA PMID: 40591730

Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-labe (41248770)

Sayed CJ, Kirby B, Garg A, Naik HB, Kimball AB, Zouboulis CC, Jemec GBE, Kokolakis G, Ingram JR, Morita A, Deherder D, Crater C, Rolleri RL, Vaux T, Lambert J, Lukowski B, Bechara FG PMID: 41248770

Improving isotretinoin adherence through a patient navigator: A pilot study in a safety net population. (41203209)

Hernandez Y, Supapannachart K, Chang T, Klufas D, Coates S, Chang AY, Amerson EH PMID: 41203209

Improving isotretinoin adherence through a patient navigator: A pilot study in a safety net population. (41203209)

Hernandez Y, Supapannachart K, Chang T, Klufas D, Coates S, Chang AY, Amerson EH PMID: 41203209